We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,599.50 | 1,604.00 | 1,605.00 | 1,612.50 | 1,591.00 | 1,600.50 | 5,248,767 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.40 | 66.06B |
Date | Subject | Author | Discuss |
---|---|---|---|
08/10/2019 16:01 | The flaw is in the American keyboard,they like to be different | abdullla | |
08/10/2019 15:35 | I wonder why the pound sign is coming out all cryptic: � What about the dollar: $ and the Euro sign: � | solomon | |
08/10/2019 13:31 | �1 = USD 1.22 | tradermichael | |
07/10/2019 14:48 | He may be a communist! | abdullla | |
07/10/2019 13:40 | If that's the case, he'd better clean up after...spud | spud | |
07/10/2019 13:02 | Corbyn the Marxist is coming. | xxxxxy | |
05/10/2019 12:36 | On Pfizer, the merger is imminent as we're now in the last quarter of the year. Could get a bounce when the deal happens. | tradermichael | |
04/10/2019 08:26 | Any bad news will bring the price below 14,most on this board are eagerly waiting,whats happening on the Pfizer front? | abdullla | |
03/10/2019 13:11 | Sub £16 for me | iknowverylittle | |
03/10/2019 12:46 | Waiting for sub15. But not waiting for Godot | xxxxxy | |
02/10/2019 13:15 | Any buyers at 1650 this time around? ;0) | tradermichael | |
02/10/2019 10:22 | In case anyone interested "GlaxoSmithKline (GSK) Presents At ESMO Congress 2019 - Slideshow" | crossing_the_rubicon | |
01/10/2019 13:23 | The days when people used to pay attention to the brokers are long gone no body takes any notice of their blabbering mouths,the technology now rules the day. | abdullla | |
01/10/2019 08:21 | abdulla - zero out of ten. | quepassa | |
30/9/2019 09:55 | In the FTSE 100, GlaxoSmithKline was the best performer, up 2.0% after the drugmaker said its GSK3359609 cancer treatment delivered "promising anti-tumour activity" in head and neck squamous cell carcinoma. Alliance News | philanderer | |
30/9/2019 08:19 | Will it hit the 18 pounder | abdullla | |
27/9/2019 15:15 | Outcome: Collapse of Pharma research in the UK - transfer to India/China etc. Financial incentive to discover and develop new medicines seriously impacted. Nation's health and wealth compromised. | tradermichael | |
27/9/2019 14:14 | Corbyn's Marxist plan: compulsory licensing of patented medicines/state ownership of generics manufacture/give it all away with free prescriptions | tradermichael | |
27/9/2019 14:09 | GSK is still the cheapest amongst the large pharmas | abdullla | |
27/9/2019 14:08 | Yes, this is Corbyn's plan to destroy innovative pharma research in the UK: Corbyn announced a major new policy of a state-owned generic drug manufacturer to supply cheaper medicines to the NHS. This would stop big pharmaceutical companies charging the NHS over the odds for medicines. “We will redesign the system to serve public health – not private wealth – using compulsory licensing to secure generic versions of patented medicines,” he said. “We’ll tell the drugs companies that if they want public research funding then they’ll have to make their drugs affordable for all. And we will create a new publicly owned generic drugs manufacturer to supply cheaper medicines to our NHS, saving our health service money and saving lives.” | tradermichael | |
27/9/2019 14:08 | I believe that lsst Sunday's Mail suggested a positive cancer drug announcement this week. Even allowing for GSK's annoying habit of making announcements at midday rather than 7:00 am there is no sign of any such announcement this week. | zeppo | |
27/9/2019 13:57 | Corbyn could be a headache. GSK good company though. Just Corbyn and Mometum could make it pricey. | xxxxxy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions